Aarogyavat Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 1.00 M
as on 09-07-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.52 Cr
as on 09-07-2024
- Satisfied Charges ₹ 6.00 M
as on 09-07-2024
- Revenue -24.64%
(FY 2022)
- Profit -45.26%
(FY 2022)
- Ebitda 36.29%
(FY 2022)
- Net Worth 56.93%
(FY 2022)
- Total Assets 94.06%
(FY 2022)
About Aarogyavat Pharmacy
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.52 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pragati Patil, Rajendra Shinde, Aniket Mane, and One other member serve as directors at the Company.
- CIN/LLPIN
U74990MH2019PTC319714
- Company No.
319714
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mulund East, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aarogyavat Pharmacy?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pragati Patil  | Director | 14-Dec-2021 | Current |
| Rajendra Shinde | Director | 04-Apr-2022 | Current |
| Aniket Mane | Director | 16-Jan-2019 | Current |
| Gopal Danee | Director | 16-Jan-2019 | Current |
Financial Performance of Aarogyavat Pharmacy.
Aarogyavat Pharmacy Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 24.64% decrease. The company also saw a substantial fall in profitability, with a 45.26% decrease in profit. The company's net worth Soared by an impressive increase of 56.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarogyavat Pharmacy?
In 2022, Aarogyavat Pharmacy had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aarogyavat Ambulances Private LimitedActive 2 years 11 monthsPragati Patil, Aniket Mane and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2021 | ₹2.52 Cr | Open |
Others Creation Date: 04 Sep 2021 | ₹2.00 Cr | Open |
The Kunbi Sahakari Bank Limited Creation Date: 24 Jan 2020 | ₹6.00 M | Satisfied |
How Many Employees Work at Aarogyavat Pharmacy?
Unlock and access historical data on people associated with Aarogyavat Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarogyavat Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarogyavat Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
